ORIC NASDAQ
ORIC Pharmaceuticals, Inc.
1W: -7.2%
1M: -7.0%
3M: +11.9%
YTD: +49.5%
1Y: +4.3%
3Y: +89.9%
5Y: -48.6%
$12.21
-0.32 (-2.52%)
Weekly Expected Move ±6.5%
$11
$11
$12
$13
$14
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-05-06
Earliest Filing
2021-05-06
Latest Filing
partner: 1
Counterparties (Filed by ORIC)
1 relationshipsCompanies named in ORIC's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-03 | Earnings Release; Exhibits | View | |
| 2026-07-30 | Officer/Director Change; Exhibits | View | |
| 2026-06-22 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-04 | Earnings Release; Exhibits | View | |
| 2026-03-31 | Other Events; Exhibits | View | |
| 2026-02-23 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Fi | View | |
| 2025-06-13 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-05-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-14 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-02-25 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-18 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR